Pharmaceutical Supply for Indian Army Personnel

Work Description - NA

This tender, issued by the Department of Military Affairs under the Ministry of Defence for the Indian Army, presents a significant opportunity for suppliers of essential pharmaceuticals. The bid, numbered GEM/2026/B/7661612, encompasses a diverse and extensive range of medications totaling 742,042 units. Key items include topical treatments such as Tacrolimus ointment, Triamcinolone acetonide, Halobetasol propionate, and Ketoconazole cream, alongside a variety of oral medications. Notable oral formulations are Tabs Acetylcystane with Taurine, Telmisartan, Tenofovir, Ticagrelor, Tolperisone, Torsemide with Spironolactone, Trihexyphenidyl HCl, Trimetazidine, Valsartan, Voglibose, Zolpidem, Acebrophylline, Amantadine, and combination tablets like Glimepiride with Metformin. The tender also includes respiratory medications such as Beclomethasone Dipropionate and Budesonide with Formeterol inhalers, and Respules for nebulization. Additionally, a broad spectrum of topical and oral preparations for pain management, dermatological conditions, and general wellness are listed, including SYP TRICHOLINE CITRATE SORBITOL, TENDOCARETABlet, ACNEEXCELA LOTION, ALOVERA AND VITAMIN ELOTION, Azelaic acid cream, Syp Guaiphenesin, BROMELAIN TRYPSIN RUTOSIDE, caroverine capsules, Diclofenac diethylamine spray, DIMENHYDRINATE TAB, and Syp Disodium hydrogen Citrate. This comprehensive requirement underscores the Indian Army's commitment to maintaining the health and well-being of its personnel. The bidding period is scheduled to commence on August 18, 2026, at 6:00 PM and will conclude on August 19, 2026, at 7:00 PM, providing a clear timeframe for interested parties to submit their proposals.